IPCA LABORATORIES LTD. - 524494 - Standalone And Consolidated Unaudited Financial Results For Q1FY25

Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer

1387.3000 -39.70 (-2.78%)

NSE Aug 06, 2025 15:47 PM

Volume: 132.7K

Ipca Laboratories Ltd.

13 Aug 2024

1387.30

-2.78%

Result

IPCA LABORATORIES LTD. - 524494 - Standalone And Consolidated Unaudited Financial Results For Q1FY25

BSE India

Standalone and Consolidated Unaudited Financial Results for Q1FY25

More from Ipca Laboratories Ltd.

Recommended

Market closes lower, Lupin's Q1 net profit surges 52.1% YoY to Rs 1,219 crore

Trendlyne Marketwatch | 06 Aug 2025, 03:56PM

Five stocks to buy from analysts this week - August 6, 2025

The Baseline | 06 Aug 2025, 10:55AM

IPCA Labs’ domestic formulations business to drive growth

| 05 Jul 2021, 12:21PM